Clinical Trials During the COVID-19 Pandemic and Beyond: New FDA, NIH Guidance and other Federal Agency Actions to Enable Research

Ms. Bonham is skilled healthcare attorney and nationally recognized expert in research compliance, government and internal investigations, integrity, and bioethics. She has nearly 20 years of experience in the U.S. Department of Health and Human Services as a leader in healthcare, life sciences, enforcement and public policy. Ms. Bonham served as a senior advisor in the Office of the Director of the National Institutes of Health and as a senior attorney in the Office of the General Counsel of the HHS.

Mr. Peloquin advises clients on a wide range of legal and regulatory issues in the area of clinical research and related activities. He counsels academic medical centers, life sciences companies, information technology companies and other clients that sponsor, support and conduct research. With a broad client base and knowledge of a range of laws and regulations, from the Common Rule and FDA regulations, to HIPAA and GDPR, to state and federal fraud and abuse laws—Mr. Peloquin offers clients clear, practical advice on how the complex legal landscape intersects with an array of research activities. In addition to his advisory work, Mr. Peloquin collaborates with the private equity group to conduct regulatory diligence of clinical research investments and works with the firm’s litigation practice on government and civil investigations involving clinical research. He speaks and writes frequently on issues in healthcare law and data privacy.